Gülçin ŞİMŞEK, Serpil OĞUZTÜZÜN, Servet GÜREŞCİ, Murat KILIÇ, Ömer Faruk BOZKURT, Ali ÜNSAL

The expression of GST isoenzymes in acinar adenocarcinoma, intraepithelial neoplasia, and benign prostate tissue: correlation of clinical parameters with GST isoenzymes

This study investigated the immunohistochemical staining characteristics of glutathione-S-transferase (GST) alpha, pi, mu, and theta in prostatic acinar adenocarcinoma (PCA), prostatic intraepithelial neoplasia (PIN), and benign prostatic tissues from 19 patients. Relationships between GST isoenzyme expression in benign, PIN, and PCA tissue were examined by the Wilcoxon signed-rank test and clinicopathological data were examined by the Spearman correlation rank test. When the benign, PIN, and PCA tissues from these cases were compared according to their staining intensity, GST alpha, pi, mu, and theta expressions in tumor cells were significantly lower than in benign epithelial cells (P < 0.05). The GST alpha class displayed the lowest level of expression in PIN and PCA. Expression of GST pi was lower in PCA tissue than in PIN and benign epithelial tissue (P < 0.05). We hypothesize that carcinogenesis in the prostate results from impaired cellular handling of mutagenic agents owing to reduction or loss of expression of multiple GST isoenzymes and other detoxifying and antimutagenesis agents. This study confirms the down-regulation of GST isoenzymes in PCA of the prostate and shows that the loss of GST isoenzyme expression is a phenotype associated with malignant transformation. There was no statistical relationship between GST isoenzyme expression and the clinicopathological data (age, Gleason score, and total serum prostate-specific antigen levels) (P > 0.05).

Anahtar Kelimeler:

Key words: Prostate acinar adenocarcinoma, prostatic intraepithelial neoplasia, glutathione-S-transferase, immunohistochemistry

The expression of GST isoenzymes in acinar adenocarcinoma, intraepithelial neoplasia, and benign prostate tissue: correlation of clinical parameters with GST isoenzymes

Keywords:

prostatic intraepithelial neoplasia, glutathione-S-transferase, immunohistochemistry, Prostate acinar adenocarcinoma,

PDF

___

Di Ilio C, Aceto A, Bucciarelli T et al. Glutathione transferase isoenzymes from human prostate. Biochem J 271: 481−5, 1990.
Bostwick DG, Meiers I, Shanks JH. Glutathione S-transferase: differential expression of a, l, and p isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma. Human Pathol 38: 1394−401, 2007.
Oğuztüzün S, İşcan M, Özhavzalı M et al. Comparison of GST isoenzymes expression in normal and tumor breast tissue: correlation with clinical and prognostic factors. Turk J Biol 33: 89−100, 2009.
Aydin S, Oguztuzun S, Gurbuz N et al. Immunohistochemical localization of GST isoenzymes (GSTA, GSTP, GSTM4 and GSTT1) and tumor marker P53 in matched larynx tissue from normal and carcinoma: correlations with the prognostic factors. J Otolaryngol Head Neck Surg 39; 5: 542−50, 2010.
Oğuztüzün S, Sezgin Y, Yazıcı S et al. Expression of glutathione- S-transferases isoenzymes and p53 in exfoliated human bladder cancer cells. Urol Oncol 17: 1−7, 2009.
Oğuztüzün S, Aydın M, Demirağ F et al. The expression of GST isoenzymes and p53 in non-small cell lung cancer. Folia Histochem Cytobiol 48: 122−7, 2010.
Moskaluk CA, Duray PH, Cowan KH et al. Immunohistochemical expression of pi-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate. Cancer 79: 1595−9, 1997.
Murray GI, Taylor VE, McKay JA et al. The immunohistochemical localization of drug-metabolizing enzymes in prostate cancer. J Pathol 177: 147−52, 1995.
Coles B, Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 25: 47−70, 1990.
Cairns J, Wright C, Cattan AR et al. Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas. J Pathol 166: 19−25, 1992.
Gilbert L, Elwood LJ, Merino M et al. A pilot study of pi- class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 11: 49−58, 1993.
Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2: 210−9, 2002.
Jeronimo C, Usadel H, Henrique R et al. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst 93: 1747−52, 2001.
Yamanaka M, Watanabe M, Yamada Y et al. Altered methylation of multiple genes in carcinogenesis of the prostate. Int J Cancer 106: 382−7, 2003.
Harden SV, Sanderson H, Goodman SN et al. Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies. J Natl Cancer Inst 95: 1634−7, 2003.
Srivastava DS, Mandhani A, Mittal B et al. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. B J U Int 95: 170−3, 2005.
Hayes JD, Strange RC. Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res 22: 193−207, 1995.
Harden SV, Guo Z, Epstein JI et al. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. J Urol 169: 1138−42, 2003.
Brooks JD, Weinstein M, Lin X et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 7: 531−6, 1998.
Lee WH, Morton RA, Epstein JI et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 91: 1733−7, 1994.
Lin X, Tascilar M, Lee WH et al. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol 159: 1815−26, 2001.
Ntais C, Polycarpou A, Ioannidis JP. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 14: 176−81, 2005.
Kelada SN, Kardia SL, Walker AH et al. The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomarkers Prev 9: 1329−34, 2000.
Autrup JL, Thomassen LH, Olsen JH et al. Glutathione S-transferases as risk factors in prostate cancer. Eur J Cancer Prev 8: 525−32, 1999.
Acevedo C, Opazo JL, Huidobro C et al. Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people. Prostate 57: 111−7, 2003.
Agalliu I, Langeberg WJ, Lampe JW et al. Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle aged men. Prostate 66: 146−56, 2006.
Kidd LC, Woodson K, Taylor PR et al. Polymorphisms in glutathione-S-transferase genes (GST-M1, GST-T1 and GST-P1) and susceptibility to prostate cancer among male smokers of the ATBC cancer prevention study. Eur J Cancer Prev 12: 317−20, 2003.
Beer TM, Evans AJ, Hough KM et al. Polymorphisms of GSTP1 and related genes and prostate cancer risk. Prostate Cancer Prostatic Dis 5: 22−7, 2002.
Gsur A, Haidinger G, Hinteregger S et al. Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer 95: 152−5, 2001.
Kote-Jarai ZED, Edwards SM, Jefferies S et al. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics 11: 325−30, 2001.
Wadelius M, Autrup JL, Stubbins MJ et al. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 9: 333−40, 1999.
Shepard TF, Platz EA, Kantoff PW et al. No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev 9: 1267−8, 2000.
Debes JD, Yokomizo A, McDonnell SK et al. Gluthatione-S- transferase P1 polymorphism I105V in familial and sporadic prostate cancer. Cancer Genet Cytogenet 155: 82−6, 2004.
Luscombe CJ, French ME, Liu S et al. Glutathione S-transferase GSTP1 genotypes are associated with response to androgen ablation therapy in advanced prostate cancer. Cancer Detect Prev 26: 376−80, 2002.
Mao GE, Morris G, Lu QY et al. Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer Detect Prev 28: 368−74, 2004.